Portfolio Holdings Detail for ISIN IE00B3VWM098

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE

Holdings detail for ENFN

Show aggregate ENFN holdings

News associated with ENFN

Harbor Capital Advisors Inc. Purchases 2,366 Shares of Enfusion, Inc. (NYSE:ENFN)

Harbor Capital Advisors Inc. grew its position in Enfusion, Inc. (NYSE:ENFN – Free Report) by 30.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,201 shares of the company’s stock after purchasing an additional 2,366 shares during the period. […] - 2025-06-16 04:46:53

Enfusion, Inc. (NYSE:ENFN) Shares Bought by Mackenzie Financial Corp

Mackenzie Financial Corp grew its position in Enfusion, Inc. (NYSE:ENFN – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 31,271 shares of the company’s stock after acquiring an additional 1,434 shares during the period. Mackenzie Financial Corp’s holdings in Enfusion […] - 2025-06-05 05:24:55

ProShare Advisors LLC Buys Shares of 13,983 Enfusion, Inc. (NYSE:ENFN)

ProShare Advisors LLC bought a new stake in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund bought 13,983 shares of the company’s stock, valued at approximately $144,000. Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Man Group plc […] - 2025-06-03 04:48:48

12,686 Shares in Enfusion, Inc. (NYSE:ENFN) Bought by Man Group plc

Man Group plc acquired a new position in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,686 shares of the company’s stock, valued at approximately $131,000. Other institutional investors have […] - 2025-05-29 04:58:52

Northern Trust Corp Has $4.56 Million Stock Holdings in Enfusion, Inc. (NYSE:ENFN)

Northern Trust Corp lifted its position in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) by 9.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 443,150 shares of the company’s stock after buying an additional 39,211 shares during the quarter. Northern Trust Corp’s holdings in Enfusion were worth $4,564,000 at the end of the […] - 2025-05-22 04:18:55

Balyasny Asset Management L.P. Purchases 25,017 Shares of Enfusion, Inc. (NYSE:ENFN)

Balyasny Asset Management L.P. lifted its position in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) by 114.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 46,943 shares of the company’s stock after purchasing an additional 25,017 shares during the period. Balyasny Asset […] - 2025-05-16 06:31:03

Tower Research Capital LLC TRC Grows Holdings in Enfusion, Inc. (NYSE:ENFN)

Tower Research Capital LLC TRC grew its stake in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) by 58.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,227 shares of the company’s stock after purchasing an additional 4,889 shares during the quarter. Tower Research […] - 2025-05-08 05:08:51

Barclays PLC Raises Position in Enfusion, Inc. (NYSE:ENFN)

Barclays PLC lifted its stake in Enfusion, Inc. (NYSE:ENFN – Free Report) by 9.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 94,141 shares of the company’s stock after buying an additional 8,102 shares during the period. Barclays PLC’s holdings in Enfusion were worth $969,000 at the end of the most recent quarter. […] - 2025-05-06 04:39:00

Marshall Wace LLP Makes New Investment in Enfusion, Inc. (NYSE:ENFN)

Marshall Wace LLP purchased a new position in Enfusion, Inc. (NYSE:ENFN – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 110,858 shares of the company’s stock, valued at approximately $1,142,000. Several other institutional investors and hedge funds have also bought and sold shares of ENFN. Barclays PLC grew its holdings […] - 2025-04-30 05:44:15

Enfusion, Inc. (NYSE:ENFN) Shares Bought by Renaissance Technologies LLC

Renaissance Technologies LLC raised its position in Enfusion, Inc. (NYSE:ENFN – Free Report) by 20.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 168,397 shares of the company’s stock after purchasing an additional 28,897 shares during the quarter. Renaissance Technologies LLC owned about 0.13% […] - 2025-04-28 04:44:51

Quantbot Technologies LP Takes Position in Enfusion, Inc. (NYSE:ENFN)

Quantbot Technologies LP bought a new position in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) during the 4th quarter, HoldingsChannel reports. The firm bought 13,950 shares of the company’s stock, valued at approximately $144,000. Several other hedge funds also recently added to or reduced their stakes in ENFN. Intech Investment Management LLC acquired a […] - 2025-03-31 04:40:55

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ENFN holdings

Share Trades of ENFN by Blackrock for IE00B3VWM098

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-04-15	SELL	-96			10.920*		10.58 Profit of 1,016 on sale
2025-04-14	SELL	-96			10.810*		10.58 Profit of 1,016 on sale
2025-04-09	SELL	-128			10.960*		10.57 Profit of 1,353 on sale
2025-04-07	SELL	-224			10.600*		10.57 Profit of 2,368 on sale
2025-04-04	SELL	-320			10.590*		10.57 Profit of 3,383 on sale
2025-03-31	BUY	32			11.150*		10.55
2025-03-19	SELL	-64			11.090*		10.50 Profit of 672 on sale
2025-03-14	SELL	-192			11.090*		10.48 Profit of 2,012 on sale
2025-03-13	SELL	-64			11.050*		10.47 Profit of 670 on sale
2025-03-12	SELL	-1,088			11.160*		10.46 Profit of 11,385 on sale
2025-03-07	SELL	-64			11.230*		10.44 Profit of 668 on sale
2025-03-06	SELL	-96			11.290*		10.43 Profit of 1,001 on sale
2025-03-03	SELL	-32			11.370*		10.39 Profit of 332 on sale
2025-02-28	SELL	-192			11.480*		10.37 Profit of 1,991 on sale
2025-02-26	SELL	-32			11.340*		10.34 Profit of 331 on sale
2025-02-25	SELL	-96			11.390*		10.33 Profit of 992 on sale
2025-02-18	BUY	160			11.120*		10.24
2025-02-13	BUY	32			11.150*		10.20
2025-02-12	BUY	32			11.060*		10.19
2025-02-11	BUY	96			11.090*		10.17
2025-02-06	BUY	288			11.220*		10.12
2025-01-27	BUY	32			11.050*		9.95
2025-01-22	SELL	-64			11.110*		9.87 Profit of 632 on sale
2025-01-17	SELL	-32			11.070*		9.79 Profit of 313 on sale
2025-01-16	BUY	32			10.960*		9.76
2025-01-14	BUY	96			10.810*		9.70
2025-01-13	BUY	64			10.810*		9.67
2025-01-08	BUY	192			10.290*		9.63
2024-12-30	BUY	160			10.470*		9.60
2024-12-06	BUY	128			10.210*		9.52
2024-12-05	BUY	32			10.000*		9.50
2024-12-04	BUY	160			10.110*		9.48
2024-11-29	BUY	160			9.940*		9.41
2024-11-27	BUY	128			10.020*		9.36
2024-11-26	BUY	32			10.130*		9.32
2024-11-21	BUY	160			10.100*		9.19
2024-11-20	BUY	96			9.890*		9.15
2024-11-18	BUY	384			9.700*		9.08
2024-11-12	BUY	256			9.500*		9.06
2024-11-08	BUY	160			9.380*		9.03
2024-11-07	BUY	480			9.300*		9.01
2024-11-06	BUY	64			9.330*		8.99
2024-10-31	BUY	32			8.910*		9.02

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ENFN

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy